1. Home
  2. OTTR vs RCUS Comparison

OTTR vs RCUS Comparison

Compare OTTR & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Otter Tail Corporation

OTTR

Otter Tail Corporation

HOLD

Current Price

$91.10

Market Cap

3.8B

Sector

Utilities

ML Signal

HOLD

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$28.66

Market Cap

3.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OTTR
RCUS
Founded
1907
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Electric Utilities: Central
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
3.8B
IPO Year
2009
2018

Fundamental Metrics

Financial Performance
Metric
OTTR
RCUS
Price
$91.10
$28.66
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
$31.90
AVG Volume (30 Days)
245.9K
1.5M
Earning Date
05-04-2026
05-05-2026
Dividend Yield
2.62%
N/A
EPS Growth
N/A
N/A
EPS
1.73
N/A
Revenue
$1,299,640,000.00
$247,000,000.00
Revenue This Year
$1.99
N/A
Revenue Next Year
$3.83
$45.62
P/E Ratio
$53.62
N/A
Revenue Growth
N/A
N/A
52 Week Low
$74.15
$8.84
52 Week High
$95.00
$31.74

Technical Indicators

Market Signals
Indicator
OTTR
RCUS
Relative Strength Index (RSI) 54.04 54.26
Support Level $84.68 $19.78
Resistance Level N/A $28.72
Average True Range (ATR) 2.21 1.42
MACD 0.19 -0.40
Stochastic Oscillator 42.89 48.55

Price Performance

Historical Comparison
OTTR
RCUS

About OTTR Otter Tail Corporation

Otter Tail Corp is a U.S. energy company that operates in the electric (produces and sells electricity), manufacturing (fabricates metal components), and plastics segments (pipes for water uses). The company conducts its operations and acquires the majority of its revenue in the U.S. in the states of Minnesota, South Dakota, and North Dakota. The majority of the company's revenue is derived from the Electric segment and commercial customers, although it generates revenue from residential and industrial customers, as well.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.

Share on Social Networks: